Keytruda combination treatment for NSCLC falls short in Phase III – Pharmaceutical Technology
Share this article The Keytruda / Lynparza treatment is being studied as a first-line treatment for certain types of patients with NSCLC. Credits: Sonis Photography/Shutterstock.com